6.04%GE 20.43 5.29%QQQQ 33.82 6.52%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Teva Pharmaceutical Industries Ltd. said Tuesday a U.S. court ruled against it in an ongoing patent challenge over the anti-psychotic drug Seroquel and the Israel-based drug developer plans to appeal the decision.
Teva is challenging AstraZeneca's patent claims to Seroquel in the U.S. The company, and several others, hope to sell a generic version before the U.S. patent expires on AstraZeneca's second-biggest selling drug, with $4 billion in sales in 2007.
Teva said the U.S. District Court for the District of New Jersey granted summary judgment in AstraZeneca's favor. The company did not provide details on its plan to appeal the decision.
The Obama campaign launched a campaign ad, short documentary and web site attack...
The Philippine unit of American International Group Inc. sought to dispel concerns Monday that the sale of the country's largest insurer would af...
Republicans John McCain and Sarah Palin on Friday played up her debate performan...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
-2.92
